Background
==========

The use of CMs among women seeking reproductive health care in clinical settings in relation to menopause \[[@B1]\], infertility \[[@B2]\], and pregnancy \[[@B3]\], has been investigated. A review of this literature indicates that resorting to some form of CM for fertility enhancement varies from 29% to 91% \[[@B2]\]. The Australian Longitudinal Study on Women's Health in 2006 revealed that 81% of pregnant women reported the self-prescribed use of vitamins and minerals, 33% consulted with a CM practitioner, and 19% consumed herbal medicines \[[@B3]\], and nearly one in six women in the United States reported having taken a herbal supplement in 2000 \[[@B4]\].

Motivations for CM use among women are little understood. However CM use during pregnancy is driven by women's motivations to take an active role in the maintenance of their health \[[@B5]\], a belief in a holistic approach to health and treatment \[[@B6]\], and/or an interest in 'natural therapies' that have fewer side effects \[[@B3],[@B5],[@B7],[@B8]\].

Women view CMs as safe and as at least equally efficacious as medical prescriptions \[[@B9],[@B10]\]. However, safety concerns arise from the concurrent use of conventional medical treatment with CM therapy \[[@B11]\] and poor communication about CM consumption between patients and their health care providers. A lack of disclosure of CM consumption to conventional health practitioners is not uncommon \[[@B4]\] and, consequently, interactions with medications and herbal therapies do occur. In the area of family planning (FP), which encompasses sexual and reproductive health, concerns exist for example about an interaction between St John's wort (*Hypericum perforatum*) with certain hormonal contraceptives \[[@B12]\]. Case reports of oral contraceptive (OC) failure coinciding with use of St John's wort are on record and some studies have identified potential interactions \[[@B13],[@B14]\]. A pilot study evaluating the effect of St John's wort on OC therapy brought to light a link between the resulting increased metabolism of norethindrone and ethinylestradiol, and the occurrence of breakthrough bleeding, follicular growth, and ovulation \[[@B15]\]. These findings suggest St John's wort may reduce the effectiveness of hormonal contraceptives, with the exception of depot medroxyprogesterone acetate injections and the levonorgestrel releasing-intrauterine system, whose efficacy does not appear to be impaired by the enhancement of the steroid metabolism in the liver. These findings are reflected in internationally recognised guidelines for the safe and effective provision of contraceptive methods \[[@B16]\].

Although, according to the literature, women in Australia are frequent users of CMs \[[@B2],[@B3],[@B5]\], few studies have examined their utilisation by women attending a FP service. Understanding women's use and extent of CM utilisation, patterns and motivations for use, and disclosure of CM in this clinical setting is important with assisting health care providers to promote safe and effective contraception. The aim of this study was to examine (i) the extent of and type of CM, (ii) women's views about safety and efficacy, and (iii) the factors influencing women's decision-making.

Methods
=======

We undertook a cross-sectional survey of women attending the main metropolitan urban Family Planning New South Wales (FPNSW) clinic at Ashfield in Sydney. Ethics approval was obtained from the Family Planning New South Wales Ethics Committee. Women were eligible to participate if they were 18 years of age or older, and were able to read and write English. Eligibility was confirmed from clinical notes.

An anonymous self-administered questionnaire was designed to examine previous use of CM (defined as use in the previous 12 months), and women's current use (defined as at present and ongoing) their attitudes towards safety and effectiveness, the factors influencing their decision-making, and their disclosure of CM use to a FP health professional, women attending for the first time were asked not to answer this question. Demographic questions were designed to describe the diversity of the participants including age, education, country of birth and languages spoken at home. Questions about CM use were taken from a previously published survey \[[@B10]\]. This questionnaire included a broad and inclusive definition of CM medicines and therapies, and distinguished between vitamins and mineral supplements prescribed or not prescribed by a doctor. This distinction reflects the regulatory framework in Australia where complementary medicines are regulated as medicines under the Therapeutic Goods Act1989 \[[@B17]\]. A review of other surveys was also undertaken and included those previously used by the author (CS) \[[@B5],[@B18],[@B19]\]. Consultations were also held with the medical and research directors and the research team at FPNSW to discuss content and finalise the design. CM treatments included herbal medicines, vitamin and mineral supplements, other nutritional supplements, traditional medicines such as traditional Chinese medicines, homoeopathic medicines, and aromatherapy oils (where they make therapeutic claims).

The questionnaire was piloted on ten women attending the clinic in early January 2011. After these interviews it was apparent that minor modifications to the wording of some questions were required. We did not undertake a power calculation for the sample size; instead we decided to survey all women attending the clinic who met the eligibility criteria during a two-week period in January, 2011. It was considered that this time period would generate a population that would be representative of the total population. All clinic sessions were attended by the research assistant. Women were approached by a research assistant and invited to participate in the survey. Women were informed that their participation was voluntary. Only verbal consent was obtained as completion of the self-administered questionnaire by women before or after their consultation confirmed consent.

Statistical analyses were carried out using SPSS software (the IBM Statistical Package for the Social Sciences 19, Chicago, IL). Descriptive statistics, using frequencies and percentages were calculated for demographic and categorical data, and chi-squared tests were undertaken to compare CM patterns of use with socio-demographic characteristics. We subsequently ran logistic regression models to examine the association between CM use, attitudinal data and demographics. For the nominal regression model attitude (dependent vaiable) was re-coded to three categories; agree, disagree and don't know. The co-variants included age and education, and education was re-coded to tertiary educated or not. We report on adjusted odds ratios and a 95% confidence interval. The conventional 0.05 level of significance was used to test for statistical differences.

Results
=======

Between 11 January and 24 January 2011, 221 questionnaires were distributed to eligible women. Of this convenience sample, 209 who agreed to participate in the study completed the questionnaire (94% response rate). Twelve women declined. The sample represented a varied population which spanned all eligible reproductive age groups (Table [1](#T1){ref-type="table"}). The majority of women were tertiary educated. Most were born in Australia but other nationalities were well represented, with women born in 33 other countries, who between them spoke 11 languages other than English at home. Comparing the characteristics of our study population with the profile of clients attending the Ashfield Clinic at FPNSW, we found our sample had a similar age profile and country of birth to the women attending the Ashfield clinic, however our study population was represented by a greater proportion of women who spoke only English at home (p = 0.01), and whose education profile differed (p \< 0.01). Ashfield is one of the most culturally diverse communities in inner Sydney with 43% of the population born overseas.

###### 

Characteristics of women participating in the survey and women attending the clinic

                               **Women participating in the survey (n = 209)**    **All women attending Ashfield clinic in 2011 (n = 6242)**   ***p*-value**                                            
  ---------------------------- ------------------------------------------------- ------------------------------------------------------------ --------------- ------------- ------ ------ ------------- ------------
  Age                                                                                                                                                                                                   
                               18--24 years                                                                   43                                   20.5        (15.3-26.7)   946    15.1   (14.2-16.0)   p = 0.113
                               25--34 years                                                                   56                                   26.7        (20.9-33.3)   1907   30.5   (29.4-31.7)  
                               35--44 years                                                                   48                                   22.9        (17.4-29.2)   1629   26.1   (25.0-27.2)  
                               45 + years                                                                     54                                   25.8        (20.0-32.3)   1760   28.2   (27.0-29.3)  
                               Missing data                                                                   8                                     3.8         (1.6-7.4)                                     
  Highest level of education                                                                                                                                                                            
                               Did not finish high-school                                                     8                                     3.8         (1.6-7.4)                                     
                               Finished high-school\*                                                         32                                   15.3        (10.7-20.9)   1850   29.6   (28.5-30.7)   p \< 0.001
                               TAFE or similar\#                                                              52                                   24.8        (19.1-31.3)   1368   21.9   (20.9-22.9)  
                               University degree                                                             108                                   51.6        (44.6-58.6)   2962   47.4   (46.2-48.7)  
                               Missing data                                                                   9                                     4.3         (1.9-8.0)                               
  Country of birth                                                                                                                                                                                      
                               Australia                                                                     130                                   62.2        (55.2-68.8)   3616   57.9   (56.6-59.1)   p = 0.218
                               United Kingdom                                                                 9                                     4.3         (1.9-8.0)    328    5.2     (4.7-5.8)   
                               New Zealand                                                                    6                                     2.8         (1.0-6.1)    186    2.9     (2.5-3.4)   
                               China                                                                          6                                     2.8         (1.0-6.1)    405    6.4     (5.9-7.1)   
                               Other                                                                          49                                   23.4        (17.8-29.7)   1707   27.3   (26.2-28.4)  
                               Missing data                                                                   9                                     4.3         (1.9-8.0)                               
  Language spoken at home                                                                                                                                                                               
                               English                                                                       183                                   87.5        (82.3-91.7)   5297   84.8   (83.9-85.7)   p = 0.014
                               Other                                                                          18                                    8.6        (5.1-13.2)    945    15.1   (14.2-16.0)  
                               Missing data                                                                   8                                     3.8         (1.6-7.4)                               

\*Finished high school only; \#TAFE, Technical and further education institute.

Due to rounding not all percentages add up to 100%.

Patterns of CM use
------------------

Eighty-three percent (95% CI 78.0-88.4) of women reported they had used CM products within the previous 12 months, and 67% (95% CI 60.6-73.7) of the sample indicated they were currently using CM products (Table [2](#T2){ref-type="table"}). The most popular CM products included vitamins and minerals. Consultations with complementary therapists in the previous 12 months were common, with 70 (33%), 95% CI 27.1-40.3) women reporting visits; a smaller number of women were currently seeing a CM practitioner (Table [2](#T2){ref-type="table"}).

###### 

Use of complementary medicine and therapies (CM) by women

  ***Complementary medicines n = 209***                                                          **Complementary medicines use in previous 12 months**                            **Currently using complementary medicines**                                         
  -------------------------------------------------------------------------------- --------------------------------------------------------------------------------- --------------------------------------------------------------------- ------------- ----- ------ -------------
  Any use of CM                                                                                                           175                                                                        83.7                                   (78.0-88.4)   141   67.4   (60.6-73.7)
  Vitamins not prescribed by a doctor                                                                                     117                                                                        55.9                                   (48.9-62.8)   79    37.8   (31.2-44.7)
  Vitamins prescribed by a doctor                                                                                         32                                                                         15.3                                   (10.7-20.9)   20    9.5    (5.9-14.3)
  Mineral supplements not prescribed by a doctor (e.g., zinc, calcium, selenium)                                          73                                                                         34.9                                   (28.4-41.8)   50    23.9   (18.3-30.2)
  Mineral supplements prescribed by a doctor (e.g., zinc, calcium, selenium)                                              36                                                                         17.2                                   (12.3-23.0)   11    5.2     (2.6-9.2)
  Other natural medicines from fish or animals (e.g., fish oils)                                                          73                                                                         34.9                                   (28.4-41.8)   40    19.1   (14.0-25.1)
  Herbal teas for health reasons (e.g., valerian, peppermint)                                                             72                                                                         34,4                                   (28.0-41.3)   45    21.5   (16.1-27.7)
  Other herbal medicine (e.g., evening primrose oil, black cohosh)                                                        40                                                                         19.1                                   (14.0-25.1)   19    9.0    (5.5-13.8)
  Chinese traditional medicines (e.g., Chinese herbs)                                                                     22                                                                         10.5                                   (6.7-15.5)     9    4.3     (1.9-8.0)
  Aromatherapy oils for medicinal purposes                                                                                22                                                                         10.5                                   (6.7-15.5)     7    3.3     (1.3-6.7)
  Homoeopathic medicines                                                                                                  15                                                                          7.1                                   (4.0-11.5)     8    3.8     (1.6-7.4)
  **Consultations with complementary medicine practitioner**                        **Consultation with complementary medicine practitioner in previous 12 months**   **Current consultation with a complementary medicine practitioner**                             
  Any consultation                                                                                                        70                                                                         33.5                                   (27.1-40.3)   39    18.6   (13.6-24.6)
  Chiropractor                                                                                                            26                                                                         12.4                                   (8.2-17.6)    12    5.7     (3.0-9.8)
  Acupuncturist                                                                                                           23                                                                         11.0                                   (7.0-16.1)     8    3.8     (1.6-7.4)
  Naturopath                                                                                                              20                                                                          9.5                                   (5.9-14.3)     8    3.8     (1.6-7.4)
  TCM practitioner                                                                                                        14                                                                          6.7                                   (3.7-10.9)     5    2.3     (0.7-5.4)
  Osteopath                                                                                                               12                                                                          5.7                                    (3.0-9.8)     7    3.3     (1.3-6.7)
  Other (e.g., reflexologist)                                                                                             21                                                                         10.0                                   (6.3-14.9)    11    5.2     (2.6-9.2)

Categories are not mutually exclusive; women may have been using more than one product/modality. *CI* confidence interval, *TCM* traditional Chinese medicine.

The majority of women consulted with a CM practitioner or took CMs to maintain their general health, for prevention or to support their immune system, for instance to prevent a cold (Table [3](#T3){ref-type="table"}). The most common specific health condition treated by CM related to depression and anxiety.

###### 

Current and previous complementary medicine (CM) use by health condition

  **Area of health n = 209**                                                                           **Use in previous 12 months**   **Current use**                            
  --------------------------------------------------------------------------------------------------- ------------------------------- ----------------- ------------- ---- ------ -------------
  General health (e.g., to stay healthy)                                                                            72                      34.4         (28.0-41.3)   61   29.1   (23.2-35.8)
  Preventative care (e.g., prevent a cold)                                                                          36                      17.2         (12.3-23.0)   18   8.6    (5.1-13.2)
  Support immune system                                                                                             29                      13.8         (9.4-19.3)    18   8.6    (5.1-13.2)
  Depression/anxiety                                                                                                21                      10.0         (6.3-15.1)    14   6.7    (3.7-10.9)
  Dysmenorrhoea                                                                                                     14                       6.7         (3.7-10.9)    8    3.8    (1.60-7.4)
  Sleeping problems/ insomnia                                                                                       16                       7.6         (4.4-12.1)    7    3.3     (1.3-7.6)
  Premenstrual symptoms                                                                                             13                       6.2         (3.3-10.6)    10   4.7     (2.3-8.6)
  Skin condition                                                                                                    12                       5.7          (3.0-9.8)    6    2.8     (1.0-6.1)
  Menopausal symptoms                                                                                               10                       4.7          (2.3-8.6)    8    3.8     (1.6-7.4)
  Others (e.g., back pain, neck pain, stress, digestion, cramps, cystitis, subfertility, arthritis)                 63                      30.1         (24.0-36.8)   31   14.8   (10.3-20.3)

Categories are not mutually exclusive; women may have been using CM for more than one area of their health.

CI, confidence interval.

Thirty-four women never utilised CMs. Their reasons included: no need (n = 27), cost (n = 17), doctor or nurse has not recommended it (n = 5), lack of information about therapies available (n = 4), lack of information about safety (n = 3), or no interest (n = 1).

Our logistic regression analysis show a significant relationship between young women reporting less previous use (OR 0.23, 95% CI 0.07-0.72, *p* = 0.01) and current CM use (OR 0.24, 95% 0.09-0.61, *p* = 0.03). We also found that those not completing high school education were less likely to utilise CM (OR 0.39, 95% 0.15-1.02, *p* = 0.05). We found no relationship between CM use and the language spoken at home (Table [4](#T4){ref-type="table"}).

###### 

Logistic model of complementary medicine use among women by demographic variables

  **Independent variables**            **Dependent variables**                                                              
  ------------------------------------ ---------------------------- ----------- -------------- ------ ------ -------------- ------
  *Model 1: Age*                                                                                                            
                                       18-24                           0.23      (0.07, 0.72)   0.01   0.24   (0.09, 0.61)   0.03
                                       25-34                           0.85      (0.24, 2.96)   0.79   0.52   (0.20, 1.31)   0.16
                                       35-44                           0.51      (0.15, 1.68)   0.26   0.34   (0.13, 0.88)   0.02
                                       45+                           reference    reference                                 
  *Model 2: Education*                                                                                                      
                                       Did not finish high school      0.39      (0.15, 1.02)   0.05   0.44   (0.20, 1.00)   0.05
                                       Finished high school            0.68      (0.74, 6.32)   0.73   0.70   (0.12, 4.08)   0.70
                                       TAFE or similar                 0.65      (0.26, 1.64)   0.36   0.66   (0.32, 1.36)   0.27
                                       University degree             reference    reference                                 
  *Model 3: Language spoken at home*                                                                                        
                                       English                          1.5      (0.48, 5.15)   0.44   1.08   (0.38, 3.04)   0.87
                                       Other                         reference    reference                                 

*OR* Odds Ratio, *CI* confidence interval, *TAFE* Technical and further education institute.

Attitudes towards safety and effectiveness of CM
------------------------------------------------

Women's responses about the safety of CM indicate that many may lack information to make an informed response to these statements; a third of them selected a 'don't know' answer (Table [5](#T5){ref-type="table"}).

###### 

Survey participants' beliefs and views about complementary medicines

  **n = 209**                                          **Strongly disagree**   **Disagree**   **Agree**   **Strongly agree**   **Don't know**                                                                        
  --------------------------------------------------- ----------------------- -------------- ----------- -------------------- ---------------- ----------- ---- ------ ----------- ---- ----- ---------- ---- ------ -----------
  **I only use**                                                                                                                                                                                                           
  **CM as a last resort**                                       42                 20.1       14.8-26.1           84                40.1        33.4-47.1   25   11.9   7.8-17.1    2    0.9   0.12-3.4   45   21.5   16.1-27.7
  **CMs are not as risky as prescribed medication**             11                 5.2         2.6-9.2            62                29.6        23.5-36.3   67   32.0   25.7-38.8   17   8.1   4.8-12.7   37   17.7   12.7-23.5
  **CMs can cause dangerous side effects**                      19                 9.0        5.5-13.8            60                28.7        22.6-35.3   45   21.3   16.1-27.7   9    4.3   1.9-8.0    61   29.1   23.1-35.8
  **Ingredients in CM make them safe to use**                   11                 5.2         2.6-9.2            40                19.1        14.0-25.1   68   32.5   26.2-39.3   7    3.3   1.3-6.7    69   33.0   26.6-39.8

Percentages may not add up to 100% due to rounding.

Using a multinominal logistic regression we explored the association between attitudes towards safety and effectiveness (dependent variables), and age and education (covariants). Based on our findings in Table [4](#T4){ref-type="table"} the demographics of age and education were selected to examine if they would predict the direction of women's attitudes. We found no significant individual effects of age and education on attitudes (Table [6](#T6){ref-type="table"}).

###### 

Multinominal regression of participants' beliefs and views about complementary medicines by demographic variables

  **n = 209**                                         **OR**   **95% CI**   
  --------------------------------------------------- -------- ------------ -------------
  **I only use CM as a last resort**^**a**^                                 
  *Disagree*                                                                
  Age                                                 18--24   1.60         (0.43-6.0)
                                                      25--34   2.68         (0.58-12.4)
                                                      35--44   1.38         (0.34-5.63)
                                                      45+      0^b^         
  Tertiary Education                                                        
                                                      No       3.26         (0.80-13.3)
                                                      Yes      0^b^          
  *Don't know*                                                              
  Age                                                 18--24   0.52         (0.16-1.61)
                                                      25--34   2.11         (0.58-7.67)
                                                      35--44   0.91         (0.29-2.83)
                                                      45+      0^b^          
  Tertiary Education                                                        
                                                      No       1.81         (0.48-6.8)
                                                      Yes      0^b^          
  **CMs are not as risky as prescribed medication**                         
  *Disagree*                                                                
  Age                                                 18--24   2.59         (0.84-8.0)
                                                      25--34   0.68         (0.21-2.1)
                                                      35--44   1.05-        (0.33-3.35)
                                                      45+      0^b^         
  Tertiary Education                                                        
                                                      No       1.08         (0.37-3.15)
                                                      Yes      0^b^          
  *Don't know*                                                              
  Age                                                 18--24   1.05         (0.40-2.77)
                                                      25--34   0.61         (0.26-1.43)
                                                      35--44   0.77         (0.31-1.89)
                                                      45+      0^b^         
  Tertiary Education                                                        
                                                      No       1.3          (0.55-3.14)
                                                      Yes      0^b^          
  **CMs can cause dangerous side effects**                                  
  *Disagree*                                                                
  Age                                                 18--24   1.73         (0.59-5.03)
                                                      25--34   0.81         (0.29-2.24)
                                                      35--44   0.75         (0.26-2.09)
                                                      45+      0^b^         
  Tertiary Education                                                        
                                                      No       0.81         (0.31-2.08)
                                                      Yes      0^b^          
  *Don't know*                                                              
  Age                                                 18--24   1.70         (0.57-5.04)
                                                      25--34   1.56         (0.60-4.06)
                                                      35--44   1.17         (0.43-3.12)
                                                      45+      0^b^          
  Tertiary Education                                                        
                                                      No       0.81         (0.21-1.49)
                                                      Yes      0^b^         
  **Ingredients in CM make them safe to use**                               
  *Disagree*                                                                
  Age                                                 18--24   1.72         (0.64-4.6)
                                                      25--34   0.43         (0.17-1.1)
                                                      35--44   0.79         (0.30-2.1)
                                                      45+      0^b^         
  Tertiary Education                                                        
                                                      No       1.28         (0.49-3.38)
                                                      Yes      0^b^         
  *Don't know*                                                              
  Age                                                 18--24   0.74         (0.23-2.37)
                                                      25--34   0.47         (0.17-1.29)
                                                      35--44   1.11         (0.30-2.10)
                                                      45+      0^b^         
  Tertiary Education                                                        
                                                      No       1.99         (0.73-5.41)
                                                      Yes      0^b^         

the reference category is agree.

b this parameter is set to zero because it is redundant.

OR, Odds Ratio, CI, confidence interval; CM complementary medicine.

Views about CM and reasons for use
----------------------------------

Forty-nine percent of women considered CM as being a '*more natural*' benefit. Less frequently mentioned advantages of CM utilisation included '*better than taking drugs*' (44%), '*can complement existing health care*' (40%), '*effective, seems to work*' (38%), '*offers a form of self-care*' (36%), '*has a focus on prevention*' (35%), '*a lack of side effects*' (29%), and *'is perceived to be safe*' (21%). The disadvantages of CMs were viewed as being '*expensive*' (37%), '*a lack of research on how it works*' (28%), and '*uncertain if it will work*' (26%).

Information and communication
-----------------------------

Information on CM was mainly obtained from family and friends (50%), the internet (49%), printed material (books and magazines 49%), health professionals (38%), and CM practitioners (25%).

Women who had used CM in the previous 12 months were asked if they discussed their self prescribing use of CM or consultation with a CM practitioner during their FP consultation. Forty-four percent of participants had; those who had not indicated that they considered CM unrelated to consultation at FPNSW (43%), did not view CM as a medicine (30%) or were worried about discussing this with their doctor or nurse (5%). Two women explained in an open response that they had not mentioned it because they were not asked.

Discussion
==========

Over 80% of women attending the metropolitan Family Planning New South Wales (FPNSW) clinic at Ashfield we surveyed had visited a CM practitioner or used CMs in the previous 12 months, and two thirds were currently using CMs. Our study highlights the popularity of dietary supplements, including vitamins and minerals, and consultation with chiropractors and acupuncturists. This population reported using CM for health maintenance and self care. The advantages of CMs identified by participants included enhanced self-care, perceived safety, and being 'natural'. Most participants did not mention their CM use because they considered this information irrelevant to their clinical consultation (rather than out of a fear of rejection); because they had not been asked; or because this information had been dismissed after disclosure.

Although the prevalence of CM use we recorded was slightly higher than that (74.4%, 95% CI 70.7--78.1) reported in the last national survey undertaken in Australia \[[@B20]\], it is consistent with that observed by other authors among pregnant Australian women \[[@B3]\]. A cohort study has shown that women who consulted with CM practitioners had increased over time, with 9%, 16%, 21% and 33% of women consulting a CM practitioner in 1996, 2000, 2003, and 2006, respectively \[[@B3]\] The slightly higher rate of CM utilisation in our study may be explained by the fact that women attending a FP service may be more likely to use CM for self care or consult with practitioners, or our definition of CMs.

Women accessed information on CMs most frequently from non-medical sources including the internet, family and friends. These findings are supported by other studies from different clinical populations \[[@B20]\]. Forty-four percent of clients mentioned their consultations and self-prescribed use of CM to their healthcare provider. There are no reported studies of a general clinic population with which to compare our findings. However a study of pregnant women in the USA suggests similar levels of non-disclosure (52%) to health care providers \[[@B21]\].

We have shown that many women combine conventional health care with self-administered CM and consultations with CM practitioners. The findings also highlight that some women have limited awareness of the importance of disclosing CM use to the practitioner in the FP unit. This finding is important because the latter may, therefore, not receive full information to include in the clinical history of the patient or become aware of a potential interaction between prescribed medications and CM remedies.

The survey had a response rate of 94%, reducing the potential for a response-bias. Also the opportunity for measurement error was reduced by (i) piloting of the questionnaire, (ii) revising the instrument prior to implementation of the study, and (iii) having a researcher on site to assist with enquiries.

However, there are limitations to the study. Respondents were self-selected rather than randomly chosen, and therefore may not be representative of the clinic population as a whole. In fact we know that the sample was not representative of the larger clinic population with regard to two socio-demographic characteristics, significantly more women in the sample spoke English at home, and had a different level of education attainment than the FPNSW clinic population. Compared with national socio-demographic data the FPNSW clinic population has a slightly higher (5%) overseas born population, with a higher preference for other languages at home (5%). Our sample maybe more comparable to all family planning organisations in Australia. In addition, because we undertook a snapshot of clinic attendees during a two-week period, bias may have been introduced if there were groups of women who did not attend at this time of the year.

The questionnaire included CM modalities reporting a therapeutic claim. Our criteria may have led to some modalities being excluded, and consequently to the finding of a lower rate of utilisation than would otherwise have been the case. There is no widely accepted operational definition of CM. Wiedland \[[@B22]\] and colleagues report on an operational definition for CM therapies based on (i) therapies that rely upon non-allopathic models of health, (ii) exclusion from standard treatment within the dominant medical system, and (iii) self-care or care delivered by alternative practitioners. A lack of efficacy was not a criterion for identifying CM. If we had adopted the definition of CM described by Wiedland and co-authors', the reporting of CM use in our survey would likely to have increased. Despite these limitations, the similarities of our findings with national surveys support the validity of the study. Our results indicate that CM is widely used by women attending a FP service at an inner city clinic in Sydney.

Despite the increased awareness from research on the importance of health care providers discussing CM use with their patients, we highlight our findings in the context of a gap in knowledge in this clinical setting. Our findings also have implications for international FP programmes where use of traditional medicines (traditional Chinese medicine, Indian Ayurveda, and practices that include herbal medicines) are prevalent \[[@B23]\]. Women need to be informed that communication about use of CMs is relevant and important. Providing information and education to clinicians about what CMs are available and their benefits and risks would assist with demonstrating respect for women's use of CMs. The study has drawn attention to non disclosure of CM in this clinic and the need for clinicians to be further informed about the potential for herb-drug interactions, and to be more proactive with seeking information about CM use, particularly among women using oral contraceptives. In our study 16 women reported use of St Johns wort in the previous 12 months, and six women were currently using this herb for anxiety of depression. Due to the anonymous nature of the questionnaire we do not know if these women were using oral contraceptives, however these is the possibility of potential a herb-drug interaction arising for some women. Further discussion about CMs may also have a positive impact on satisfaction with the consultation as clients may feel they are being listened to and that their healthcare providers are interested in their personal situation.

A large number of women appear to be uninformed about the safety of CM. We did not explore the reasons for women's views towards the safety and effectiveness of CM, and this appears to be an under-researched area. Future research using qualitative designs would contribute valuable information to assist the development of appropriate communication strategies.

Conclusion
==========

We have demonstrated in our study the high frequency of CM utilisation for self-care among women attending an Australian FP clinic, however our findings may not be generalisable to all groups of women attending this clinic. We also identified a notable gap in women's awareness of the risks and benefits of CM, the potential for interactions between CM and prescribed medication, and the importance of disclosure and communication of their consultations with CM practitioners. Other healthcare providers (e.g., family physicians) who may interact with this group of women should be aware of the widespread and frequent use of CM. Our findings also emphasise the need for healthcare providers to initiate discussions with clients about their utilisation of CM.
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